Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Talk Decentralized & Hybrid track

Statistical Considerations for Effective Decentralized Clinical Trials

Tue, Feb 4, 2025 · 11:30–11:55 AM EST Rosen Shingle Creek

About this session

Decentralized Clinical Trials (DCTs) offer a patient-centered approach to engage with participants in the convenience of their homes or communities, utilizing digital health technologies (DHTs) and innovative data collection methods. DCTs provide patients with greater flexibility, reduce the need for frequent study visits, lower costs, facilitate recruitment of diverse patient populations, and potentially improve participant compliance. This presentation aims to highlight key statistical considerations involved in the design and implementation of DCTs, including selecting appropriate data types and DHTs for remote data collection, assessing data quality and completeness, determining relevant endpoints, estimating data heterogeneity, and handling missing data. We will also outline suggestions and valuable insights gained from previous DCT studies to effectively address these challenges

Speaker

  • Charmaine Demanuele

    Executive Director, AI/ML Quantitative & Digital Sciences · Pfizer

    Speaker